TY  - GEN
AU  - Romero-Zerbo, Silvana Y.
AU  - García-Fernández, María
AU  - Espinosa-Jiménez, Vanesa
AU  - Pozo-Morales, Macarena
AU  - Escamilla-Sánchez, Alejandro
AU  - Sánchez-Salido, Lourdes
AU  - Lara, Estrella
AU  - Cobo-Vuilleumier, Nadia
AU  - Rafacho, Alex
AU  - Olveira, Gabriel
AU  - Rojo-Martínez, Gemma
AU  - Gauthier, Benoit R.
AU  - González-Mariscal, Isabel
AU  - Bermúdez-Silva, Francisco J.
PY  - 2020
DO  - 10.3389/fendo.2020.00103
UR  - http://hdl.handle.net/20.500.12105/18014
AB  - Background and Aims: The synthetic atypical cannabinoid Abn-CBD, a cannabidiol (CBD) derivative, has been recently shown to modulate the immune system in different organs, but its impact in obesity-related meta-inflammation remains unstudied. We...
LA  - eng
PB  - Frontiers Media
KW  - Cannabinoids
KW  - Inflammation
KW  - Prediabetes
KW  - NAFLD
KW  - Obesity
KW  - Liver
KW  - Islets of langerhans
KW  - Adipose tissue
KW  - Cannabinoides
KW  - Inflamación
KW  - Enfermedad del hígado graso no alcohólico
KW  - Obesidad
KW  - Hígado
KW  - Islotes pancreáticos
KW  - Tejido adiposo
KW  - Adipose Tissue
KW  - Animals
KW  - Cytoprotection
KW  - Diet, High-Fat
KW  - Disease Models, Animal
KW  - Inflammation
KW  - Liver
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Obese
KW  - Fatty Liver
KW  - Obesity
KW  - Pancreas
KW  - Prediabetic State
KW  - Resorcinols
TI  - The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease
TY  - research article
ER  -